lobbying_activities: 1371716
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1371716 | b4a75c28-a21e-4904-b627-acc993b8eb6f | Q1 | DIALYSIS PATIENT CITIZENS | 400460287 | DIALYSIS PATIENT CITIZENS | 2013 | first_quarter | MMM | Ensuring Medicaid reforms included in the Affordable Care Act are implemented in a kidney disease patient-friendly manner including minimum essential coverage, premium assistance, medically frail exemption and nondiscrimination standards; In light of the recent ESRD Medicare Program rebasing efforts, requested additional guidance on erythropoiesis-stimulating agent (ESA) utilization to ensure proper patient care and reduce potential for negative patient outcomes | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2013-04-15T10:54:40.860000-04:00 |